High Lyso-Gb3 Plasma Levels Associated with Decreased miR-29 and miR-200 Urinary Excretion in Young Non-Albuminuric Male Patient with Classic Fabry Disease
Renal involvement is associated with a greater morbidity and mortality in Fabry disease. Pathological albuminuria, the first Fabry nephropathy clinical manifestation, can occur from early childhood, although histological lesions such as tubulo-interstitial fibrosis and glomerulosclerosis are present...
Saved in:
| Main Authors: | , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2019-01-01
|
| Series: | Case Reports in Nephrology |
| Online Access: | http://dx.doi.org/10.1155/2019/4980942 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1832561919947440128 |
|---|---|
| author | Sebastián Jaurretche Germán R. Perez Graciela Venera |
| author_facet | Sebastián Jaurretche Germán R. Perez Graciela Venera |
| author_sort | Sebastián Jaurretche |
| collection | DOAJ |
| description | Renal involvement is associated with a greater morbidity and mortality in Fabry disease. Pathological albuminuria, the first Fabry nephropathy clinical manifestation, can occur from early childhood, although histological lesions such as tubulo-interstitial fibrosis and glomerulosclerosis are present or may precede the onset of pathological albuminuria. In renal cells, exposure to Lyso-Gb3 is correlated with increased expression of Transforming Growth Factor-βeta (TGF-β). miR-21, miR-192, and miR-433 that promote fibrosis are activated by TGF-β, and miR-29 and miR-200 that suppress fibrosis are inhibited by TGF-β. A 23-year-old male was diagnosed with FD. αGalA decreased enzyme activity: 0.1 nmol/hour/liter; genotype: [c.317T>G (p.L106R)]; GFR: 104.4 mL/min/m2; urinary albumin excretion: 6.00 mg/day; plasma Lyso-Gb3: 124.5 nmol/L. A decrease urinary excretion of miR-29 and miR-200 was found (p <0.005) compared to controls. In addition to its usefulness as a phenotype marker, Lyso-Gb3 has been proposed as an indicator of therapeutic response. We detect an association of high Lyso-Gb3 plasma values with decreased urinary excretion of miRNAs with known antifibrotic effect (miR-29 and miR-200). Although the present work is a case report, it could be hypothesized that one of the harmful Lyso-Gb3 effects could be the miRNAs regulation through changes in TGF-β expression. |
| format | Article |
| id | doaj-art-772863c1aa034227addfda8baf25a208 |
| institution | Kabale University |
| issn | 2090-6641 2090-665X |
| language | English |
| publishDate | 2019-01-01 |
| publisher | Wiley |
| record_format | Article |
| series | Case Reports in Nephrology |
| spelling | doaj-art-772863c1aa034227addfda8baf25a2082025-02-03T01:23:57ZengWileyCase Reports in Nephrology2090-66412090-665X2019-01-01201910.1155/2019/49809424980942High Lyso-Gb3 Plasma Levels Associated with Decreased miR-29 and miR-200 Urinary Excretion in Young Non-Albuminuric Male Patient with Classic Fabry DiseaseSebastián Jaurretche0Germán R. Perez1Graciela Venera2Physiology Department, School of Medicine, Instituto Universitario Italiano de Rosario, Rosario, ArgentinaSchool of Biochemical and Pharmaceutical Sciences, National University of Rosario, Rosario, ArgentinaResearch Department, School of Medicine, Instituto Universitario Italiano de Rosario, Rosario, ArgentinaRenal involvement is associated with a greater morbidity and mortality in Fabry disease. Pathological albuminuria, the first Fabry nephropathy clinical manifestation, can occur from early childhood, although histological lesions such as tubulo-interstitial fibrosis and glomerulosclerosis are present or may precede the onset of pathological albuminuria. In renal cells, exposure to Lyso-Gb3 is correlated with increased expression of Transforming Growth Factor-βeta (TGF-β). miR-21, miR-192, and miR-433 that promote fibrosis are activated by TGF-β, and miR-29 and miR-200 that suppress fibrosis are inhibited by TGF-β. A 23-year-old male was diagnosed with FD. αGalA decreased enzyme activity: 0.1 nmol/hour/liter; genotype: [c.317T>G (p.L106R)]; GFR: 104.4 mL/min/m2; urinary albumin excretion: 6.00 mg/day; plasma Lyso-Gb3: 124.5 nmol/L. A decrease urinary excretion of miR-29 and miR-200 was found (p <0.005) compared to controls. In addition to its usefulness as a phenotype marker, Lyso-Gb3 has been proposed as an indicator of therapeutic response. We detect an association of high Lyso-Gb3 plasma values with decreased urinary excretion of miRNAs with known antifibrotic effect (miR-29 and miR-200). Although the present work is a case report, it could be hypothesized that one of the harmful Lyso-Gb3 effects could be the miRNAs regulation through changes in TGF-β expression.http://dx.doi.org/10.1155/2019/4980942 |
| spellingShingle | Sebastián Jaurretche Germán R. Perez Graciela Venera High Lyso-Gb3 Plasma Levels Associated with Decreased miR-29 and miR-200 Urinary Excretion in Young Non-Albuminuric Male Patient with Classic Fabry Disease Case Reports in Nephrology |
| title | High Lyso-Gb3 Plasma Levels Associated with Decreased miR-29 and miR-200 Urinary Excretion in Young Non-Albuminuric Male Patient with Classic Fabry Disease |
| title_full | High Lyso-Gb3 Plasma Levels Associated with Decreased miR-29 and miR-200 Urinary Excretion in Young Non-Albuminuric Male Patient with Classic Fabry Disease |
| title_fullStr | High Lyso-Gb3 Plasma Levels Associated with Decreased miR-29 and miR-200 Urinary Excretion in Young Non-Albuminuric Male Patient with Classic Fabry Disease |
| title_full_unstemmed | High Lyso-Gb3 Plasma Levels Associated with Decreased miR-29 and miR-200 Urinary Excretion in Young Non-Albuminuric Male Patient with Classic Fabry Disease |
| title_short | High Lyso-Gb3 Plasma Levels Associated with Decreased miR-29 and miR-200 Urinary Excretion in Young Non-Albuminuric Male Patient with Classic Fabry Disease |
| title_sort | high lyso gb3 plasma levels associated with decreased mir 29 and mir 200 urinary excretion in young non albuminuric male patient with classic fabry disease |
| url | http://dx.doi.org/10.1155/2019/4980942 |
| work_keys_str_mv | AT sebastianjaurretche highlysogb3plasmalevelsassociatedwithdecreasedmir29andmir200urinaryexcretioninyoungnonalbuminuricmalepatientwithclassicfabrydisease AT germanrperez highlysogb3plasmalevelsassociatedwithdecreasedmir29andmir200urinaryexcretioninyoungnonalbuminuricmalepatientwithclassicfabrydisease AT gracielavenera highlysogb3plasmalevelsassociatedwithdecreasedmir29andmir200urinaryexcretioninyoungnonalbuminuricmalepatientwithclassicfabrydisease |